Indication

As adjunctive therapy of seizures associated with  Dravet syndrome (DS) in conjunction with clobazam, for patients 2 years of age and older.

Medicine details

Medicine name:
cannabidiol (Epidyolex) (DS)
SMC ID:
SMC2262
Pharmaceutical company
GW Pharmaceuticals Ltd
Submission type
Full
Publication due date:
TBC
SMC meeting date:
TBC
Patient group submission deadline:
02 March 2020